Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Altmann

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nephron. Clinical Practice|August 7, 2003
SevelamerJane Henderson, Paul Altmann
Transfusion|April 25, 2015
Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patientsCaroline E Butler, Simon Noel, Stephen P Hibbs, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2009
Effect of pamidronate on bone loss after kidney transplantation: a randomized trialStephen B Walsh, Paul Altmann, James Pattison, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort studyKazem Rahimi, Carmelo Velardo, Andreas Triantafyllidis, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nephron. Clinical Practice|August 7, 2003
SevelamerJane Henderson, Paul Altmann
Transfusion|April 25, 2015
Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patientsCaroline E Butler, Simon Noel, Stephen P Hibbs, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2009
Effect of pamidronate on bone loss after kidney transplantation: a randomized trialStephen B Walsh, Paul Altmann, James Pattison, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort studyKazem Rahimi, Carmelo Velardo, Andreas Triantafyllidis, et al.
Pageof 1